Pejnovic named CMA president

The chief executive of Lipa Pharmaceuticals has been named president of the Australian complementary industry’s representative body. 

Dusko Pejnovic, who has been on the board of Complementary Medicines Australia since 2008, replaces Richard Henfrey, who now takes the role of vice-president. 

Dusko’s knowledge of the industry is invaluable, as is his vision for the development of the complementary medicines sector and its recognition as a vital component of the Australian healthcare landscape,” said Carl Gibson, chief executive of CMA. 

We thank Richard for his valuable contribution to the industry during his tenure as President and are delighted that he will remain an active member of the board.”